- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03572985
Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3
October 4, 2022 updated by: Taisho Pharmaceutical Co., Ltd.
Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3: Alcohol Calibration
The purpose of this study is to collect alcohol calibration data for the driving simulator.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Fukuoka, Japan
- Taisho Pharmaceutical Co., Ltd selected site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 64 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Body mass index (BMI) ≥18.5 and <25.0 kg/m^2 at screening inspection
- No visual impairment (enable to correct the vision with eyeglasses or contact lens)
- Receive a prior explanation on the study, able to accept its content, and capable to provide voluntary written consent for participation in this study
Exclusion Criteria:
- History of drug and food allergy
- Alcohol dependence, drug dependence or abnormal drunken (including past history)
- Inappropriate for enrollment in this study was judged by principal investigator or subinvestigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Blood alcohol concentration (BAC) level 0.025 %
Drink beverages containing alcohol calculated to have a blood alcohol concentration of 0.025%
|
Driving with simulator program for SDLP measurement
Driving with simulator program for BRT measurement
Driving with simulator program for DCV measurement
|
Other: BAC level 0.05 %
Drink beverages containing alcohol calculated to have a blood alcohol concentration of 0.05%
|
Driving with simulator program for SDLP measurement
Driving with simulator program for BRT measurement
Driving with simulator program for DCV measurement
|
Other: BAC level 0.09 %
Drink beverages containing alcohol calculated to have a blood alcohol concentration of 0.09%
|
Driving with simulator program for SDLP measurement
Driving with simulator program for BRT measurement
Driving with simulator program for DCV measurement
|
Other: BAC level 0 %
Drink beverages containing non alcohol
|
Driving with simulator program for SDLP measurement
Driving with simulator program for BRT measurement
Driving with simulator program for DCV measurement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Standard Deviation of Lateral Position (SDLP)
Time Frame: 60 min
|
60 min
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Distance Coefficient of Variation (DCV)
Time Frame: 5 min
|
5 min
|
Brake Reaction Time (BRT)
Time Frame: 5 min
|
5 min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 27, 2018
Primary Completion (Actual)
January 31, 2019
Study Completion (Actual)
January 31, 2019
Study Registration Dates
First Submitted
June 19, 2018
First Submitted That Met QC Criteria
June 19, 2018
First Posted (Actual)
June 28, 2018
Study Record Updates
Last Update Posted (Actual)
October 6, 2022
Last Update Submitted That Met QC Criteria
October 4, 2022
Last Verified
November 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- DS-204-03
- JapicCTI-184006 (Other Identifier: JapicCTI)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Participants
-
PfizerRecruitingHealthy Subjects | Healthy ParticipantsUnited States
-
Insmed IncorporatedRecruitingHealthy ParticipantsUnited States
-
Aeovian Pharmaceuticals, Inc.RecruitingHealthy ParticipantsAustralia
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruitingHealthy ParticipantsChina
-
CelgeneNot yet recruitingHealthy ParticipantsUnited States
-
Bristol-Myers SquibbRecruiting
-
AstraZenecaParexelRecruiting
-
ProMis Neurosciences, IncRecruiting
-
Novo Nordisk A/SRecruitingHealthy ParticipantsCanada
-
Novo Nordisk A/SRecruiting
Clinical Trials on Road-tracking test
-
Taisho Pharmaceutical Co., Ltd.Nagoya UniversityCompletedHealthy ParticipantsJapan
-
Taisho Pharmaceutical Co., Ltd.Nagoya UniversityCompletedHealthy ParticipantsJapan
-
Taisho Pharmaceutical Co., Ltd.Nagoya UniversityCompleted
-
US Department of Veterans AffairsCompletedSpinal Cord Injury | Spina Bifida | Spinal Cord DiseaseUnited States
-
National Institute for Medical Rehabilitation,...Semmelweis UniversityRecruiting
-
Seoul National University HospitalRecruitingAutomobile DrivingKorea, Republic of
-
University of MilanASST Fatebenefratelli SaccoCompleted
-
Seoul National University HospitalRecruitingAutomobile DrivingKorea, Republic of
-
Institut National de la Santé Et de la Recherche...UnknownCardiovascular Disease | Blood Pressure | Sudden Death | Community Based StudyFrance
-
University Hospital, ToursCompleted